SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)

NCT01752933 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Astex Pharmaceuticals, Inc.